Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 112 articles:
HTML format
Text format



Single Articles


    December 2017
  1. ALMARIO CV, Keller MS, Chen M, Lasch K, et al
    Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017470. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    November 2017
  2. KOCHAR B, Barnes EL, Long MD, Cushing KC, et al
    Depression Is Associated With More Aggressive Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  3. CLICK B, Anderson AM, Koutroubakis IE, Rivers CR, et al
    Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype.
    Am J Gastroenterol. 2017 Nov 7. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  4. BERNSTEIN CN, Kornbluth A
    Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1719-1721.
    PubMed     Text format     Abstract available


  5. ABE K, Nakamura N, Isono A, Toyota H, et al
    Inflammatory Bowel Disease in an Elderly Woman After Nivolumab Administration.
    Am J Gastroenterol. 2017;112:1636.
    PubMed     Text format    


    October 2017
  6. MARTIN L, Peche W, Peterson K, Wan Y, et al
    Population Based Paternity Rate and Partner Birth Outcomes Among Utah Men With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Oct 3. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available



  7. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    



  8. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    



  9. Submitted, Not Presented: Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    



  10. Submitted, Not Presented: Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    


  11. FISCHER S, Rath T, Geppert CI, Manger B, et al
    Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1621-1623.
    PubMed     Text format    


  12. ZHAO H, Xu W, Wang Z
    Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1493.
    PubMed     Text format    


  13. BUCHNER AM, Lichtenstein GR
    Editorial: Endoscopic Scoring Systems in Crohn's Disease for Evaluation of Responsiveness to Treatment: Are we Ready for the Prime Time of Endoscopic Assessment?
    Am J Gastroenterol. 2017;112:1593-1595.
    PubMed     Text format     Abstract available


  14. KHANNA R, Zou G, Stitt L, Feagan BG, et al
    Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.
    Am J Gastroenterol. 2017;112:1584-1592.
    PubMed     Text format     Abstract available


    September 2017
  15. ESTEVEZ-BOULLOSA P, Fernandez-Fernandez N, Pineda-Marino JR, Martinez-Cadilla J, et al
    Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1363.
    PubMed     Text format    


  16. BENCHIMOL EI, Kaplan GG, Otley AR, Nguyen GC, et al
    Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.
    Am J Gastroenterol. 2017;112:1485.
    PubMed     Text format     Abstract available


    August 2017
  17. GHIONE S, Sarter H, Fumery M, Armengol-Debeir L, et al
    Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.
    Am J Gastroenterol. 2017 Aug 15. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    July 2017
  18. BENCHIMOL EI, Kaplan GG, Otley AR, Nguyen GC, et al
    Rural and Urban Residence During Early Life is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.
    Am J Gastroenterol. 2017 Jul 25. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  19. YAMADA A, Komaki Y, Patel N, Komaki F, et al
    Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab.
    Am J Gastroenterol. 2017 Jul 18. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  20. ORDAS I, Domenech E, Manosa M, Garcia-Sanchez V, et al
    Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
    Am J Gastroenterol. 2017 Jul 4. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  21. DAI C, Jiang M, Sun MJ
    The Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1165.
    PubMed     Text format    


  22. MATSUSHITA M, Fukata N, Omiya M, Okazaki K, et al
    Nationwide Studies of Hematological Malignancies in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1171-1172.
    PubMed     Text format    


    June 2017
  23. MYRELID P, Landerholm K, Nordenvall C, Pinkney TD, et al
    Appendectomy and the Risk of Colectomy in Ulcerative Colitis: A National Cohort Study.
    Am J Gastroenterol. 2017 Jun 27. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  24. PATIL DT, Odze RD
    Backwash Is Hogwash: The Clinical Significance of Ileitis in Ulcerative Colitis.
    Am J Gastroenterol. 2017 Jun 20. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  25. KOMEDA Y, Kashida H, Sakurai T, Kono M, et al
    A Case of Type II Enteropathy-Associated T-Cell Lymphoma in a Patient With Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:833.
    PubMed     Text format    


    May 2017
  26. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    Corrigendum: ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 May 23. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  27. CHAPARRO M, Ramas M, Benitez JM, Lopez-Garcia A, et al
    Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.
    Am J Gastroenterol. 2017 May 23. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    April 2017
  28. BENCHIMOL EI, Bernstein CN, Bitton A, Carroll MW, et al
    Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.
    Am J Gastroenterol. 2017 Apr 18. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    March 2017
  29. TAN NY, Majumder S, Sridharan M, Kerr SE, et al
    Metastatic Epstein-Barr Virus-Positive Lymphoepithelioma-Like Cholangiocarcinoma in a Young Man With Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:518-520.
    PubMed     Text format    


  30. LIMSRIVILAI J, Shreiner AB, Pongpaibul A, Laohapand C, et al
    Meta-Analytic Bayesian Model For Differentiating Intestinal Tuberculosis from Crohn's Disease.
    Am J Gastroenterol. 2017;112:415-427.
    PubMed     Text format     Abstract available


    February 2017
  31. FUMERY M, Seksik P, Auzolle C, Munoz-Bongrand N, et al
    Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.
    Am J Gastroenterol. 2017;112:337-345.
    PubMed     Text format     Abstract available


  32. JEURING SF, van den Heuvel TR, Liu LY, Zeegers MP, et al
    Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.
    Am J Gastroenterol. 2017;112:325-336.
    PubMed     Text format     Abstract available


    January 2017
  33. MARK-CHRISTENSEN A, Brandsborg S, Laurberg S, Johansen N, et al
    Increased Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2017 Jan 24. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  34. OSTERMAN M, Gastonguay MR, Lasch K, Barocas MA, et al
    Corrigendum: 2016 ACG Abstracts-Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Text format    


  35. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  36. ANZAI H, Hata K, Ishihara S, Osada T, et al
    Caution Against the Resect-and-Discard Strategy for Dysplastic Polyps in Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:189-191.
    PubMed     Text format    


  37. MATSUSHITA M, Nishio A, Seki T, Okazaki K, et al
    Pathogenesis and Carcinogenesis of the Appendix in Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:184.
    PubMed     Text format    


    December 2016
  38. CASANOVA MJ, Chaparro M, Garcia-Sanchez V, Nantes O, et al
    Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
    Am J Gastroenterol. 2016 Dec 13. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  39. DAI C, Jiang M, Sun MJ
    Statins and the Risk of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1851.
    PubMed     Text format    


    November 2016
  40. ZIDAR N, Tepes K
    Cytomegalovirus Reactivation in Ulcerative Colitis: What Can We Learn From Pathology?
    Am J Gastroenterol. 2016;111:1658.
    PubMed     Text format    


    October 2016
  41. KHALILI H, Neovius M, Ekbom A, Ludvigsson JF, et al
    Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  42. PARK S, Abdi T, Gentry M, Laine L, et al
    Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available



  43. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  44. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  45. Submitted, Not Presented: Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  46. Submitted, Not Presented: Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    


  47. LEVENSTEIN S, Prantera C
    Psychological Factors, Symptoms, and Mucosal Inflammation in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1498-1499.
    PubMed     Text format    


  48. KHALILI H
    Editorial: Statins for Inflammatory Bowel Disease: Expanding the Scope of Prevention.
    Am J Gastroenterol. 2016;111:1424-1426.
    PubMed     Text format     Abstract available


    September 2016
  49. UNGARO R, Chang HL, Cote-Daigneaut J, Mehandru S, et al
    Corrigendum: Statins Associated with Decreased Risk of New Onset Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1370.
    PubMed     Text format    


    August 2016
  50. CHEDDANI H, Dauchet L, Fumery M, Charpentier C, et al
    Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Am J Gastroenterol. 2016 Aug 2. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  51. BILLIET T, Dreesen E, Cleynen I, Wollants WJ, et al
    A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016 Aug 2. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    July 2016
  52. LEVIN SR, Ziud H, Jimoh OY, Tseng YA, et al
    Ulcerative Colitis Presenting With Palmoplantar Neutrophilic Dermatosis.
    Am J Gastroenterol. 2016;111:923.
    PubMed     Text format    


    June 2016
  53. WANG LH, Yang YJ, Cheng WC, Wang WM, et al
    Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan.
    Am J Gastroenterol. 2016 Jun 14. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  54. UNGARO R, Chang HL, Cote-Daigneaut J, Mehandru S, et al
    Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016 Jun 14. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  55. MARIN-JIMENEZ I, Nos P, Domenech E, Riestra S, et al
    Corrigendum: Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.
    Am J Gastroenterol. 2016;111:912.
    PubMed     Text format    


  56. MARASCO G, Scaioli E, Renzulli M, Colecchia A, et al
    MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome.
    Am J Gastroenterol. 2016;111:767.
    PubMed     Text format    


    May 2016
  57. RAZIK R, Rumman A, Bahreini Z, McGeer A, et al
    Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
    Am J Gastroenterol. 2016 May 24. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  58. DEEPAK P, Fletcher JG, Fidler JL, Barlow JM, et al
    Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease.
    Am J Gastroenterol. 2016 May 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  59. TARIQ R, Smyrk T, Pardi DS, Tremaine WJ, et al
    New-Onset Microscopic Colitis in an Ulcerative Colitis Patient After Fecal Microbiota Transplantation.
    Am J Gastroenterol. 2016;111:751-2.
    PubMed     Text format    


  60. YZET C, Dupas JL, Fumery M
    Ustekinumab and Anti-TNF Combination Therapy in Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:748-9.
    PubMed     Text format    


    April 2016
  61. NEGRON ME, Rezaie A, Barkema HW, Rioux K, et al
    Ulcerative Colitis Patients With Clostridium difficile are at Increased Risk of Death, Colectomy, and Postoperative Complications: A Population-Based Inception Cohort Study.
    Am J Gastroenterol. 2016 Apr 19. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    March 2016
  62. GULAMHUSEIN AF, Eaton JE, Tabibian JH, Atkinson EJ, et al
    Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
    Am J Gastroenterol. 2016 Mar 22. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  63. GRACIE DJ, Williams CJ, Sood R, Mumtaz S, et al
    Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016 Mar 22. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  64. GISBERT JP, Marin AC, Chaparro M
    The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2016 Mar 22. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  65. ZENLEA T, Yee EU, Rosenberg L, Boyle M, et al
    Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study.
    Am J Gastroenterol. 2016 Mar 15. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  66. KABBANI TA, Koutroubakis IE, Schoen RE, Ramos-Rivers C, et al
    Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study.
    Am J Gastroenterol. 2016 Mar 8. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  67. PILLET S, Williet N, Pouvaret A, Del Tedesco E, et al
    Distribution of Cytomegalovirus DNA Load in the Inflamed Colon of Ulcerative Colitis Patients.
    Am J Gastroenterol. 2016;111:439-41.
    PubMed     Text format    


  68. MUIR A, Surrey L, Kriegermeier A, Shaikhkalil A, et al
    Severe Eosinophilic Gastroenteritis in a Crohn's Disease Patient Treated With Infliximab and Adalimumab.
    Am J Gastroenterol. 2016;111:437-8.
    PubMed     Text format    


  69. KAPLAN GG
    Smoking Cessation for Crohn's Disease: Clearing the Haze.
    Am J Gastroenterol. 2016;111:420-2.
    PubMed     Text format     Abstract available


  70. NUNES T, Etchevers MJ, Garcia-Sanchez V, Ginard D, et al
    Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study.
    Am J Gastroenterol. 2016;111:411-9.
    PubMed     Text format     Abstract available


    February 2016
  71. NARULA N, Marshall JK, Colombel JF, Leontiadis GI, et al
    Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids.
    Am J Gastroenterol. 2016 Feb 9. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  72. CZUL F, Beduschi T, Deshpande AR
    Image of the Month: A Small Bowel With Too Many Exits: An Astonishing Surgical Finding in a Patient With Crohn's Disease.
    Am J Gastroenterol. 2016;111:172.
    PubMed     Text format    


    January 2016
  73. MARIN-JIMENEZ I, Nos P, Domenech E, Riestra S, et al
    Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.
    Am J Gastroenterol. 2016 Jan 12. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  74. SVRCEK M, Beaugerie L, Kirchgesner J, Dumont S, et al
    Azathioprine May Not be Associated With Development of Colorectal Tumors With Microsatellite Instability in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:149-51.
    PubMed     Text format    


  75. PARK KT, Colletti RB, Rubin DT, Sharma BK, et al
    Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn's Disease in the United States.
    Am J Gastroenterol. 2016;111:15-23.
    PubMed     Text format     Abstract available


    November 2015
  76. PAUL S, Roblin X
    Response to Steenholdt.
    Am J Gastroenterol. 2015;110:1624-5.
    PubMed     Text format    


  77. STEENHOLDT C
    Transient and Persistent Antibodies Against TNF-Inhibitors in IBD.
    Am J Gastroenterol. 2015;110:1623-4.
    PubMed     Text format    


  78. BOLAND BS, Dulai PS, Chang M, Sandborn WJ, et al
    Pseudomonas Meningitis During Vedolizumab Therapy for Crohn's Disease.
    Am J Gastroenterol. 2015;110:1631-2.
    PubMed     Text format    


    October 2015
  79. BEWTRA M, Fairchild AO, Gilroy E, Leiman DA, et al
    Inflammatory Bowel Disease Patients' Willingness to Accept Medication Risk to Avoid Future Disease Relapse.
    Am J Gastroenterol. 2015 Oct 20. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available



  80. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2015;110 Suppl 1:S766-847.
    PubMed     Text format    


  81. KISIEL JB, Loftus EV
    Editorial: Clarity and Caution in the Natural History of Low-Grade Dysplasia in Ulcerative Colitis.
    Am J Gastroenterol. 2015;110:1473-4.
    PubMed     Text format     Abstract available


  82. FUJITA T
    An unexpected inverse association between colon adenomas and colitis.
    Am J Gastroenterol. 2015;110:1508-9.
    PubMed     Text format    


  83. CASSELL B, Gyawali CP, Kushnir VM, Gott BM, et al
    Beliefs about GI medications and adherence to pharmacotherapy in functional GI disorder outpatients.
    Am J Gastroenterol. 2015;110:1382-7.
    PubMed     Text format     Abstract available


    September 2015
  84. CHOI CR, Ignjatovic-Wilson A, Askari A, Lee GH, et al
    Low-Grade Dysplasia in Ulcerative Colitis: Risk Factors for Developing High-Grade Dysplasia or Colorectal Cancer.
    Am J Gastroenterol. 2015 Sep 29. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  85. SAHAMI S, Kooij IA, Meijer SL, Van den Brink GR, et al
    The Link between the Appendix and Ulcerative Colitis: Clinical Relevance and Potential Immunological Mechanisms.
    Am J Gastroenterol. 2015 Sep 29. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  86. KANTSO B, Simonsen J, Hoffmann S, Valentiner-Branth P, et al
    Inflammatory Bowel Disease Patients Are at Increased Risk of Invasive Pneumococcal Disease: A Nationwide Danish Cohort Study 1977-2013.
    Am J Gastroenterol. 2015 Sep 8. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  87. YAMAMOTO T, Shimoyama T
    Can Fecal Biomarkers Detect Ileal Inflammation in Inflammatory Bowel Disease?
    Am J Gastroenterol. 2015;110:1370.
    PubMed     Text format    


  88. BENCHIMOL EI, Mack DR, Nguyen GC
    Response to Fuller-Thomson.
    Am J Gastroenterol. 2015;110:1371-2.
    PubMed     Text format    


  89. FULLER-THOMSON ER
    Incidence of IBD Among Immigrants to Canada and Their Children: Could Gluten Consumption and Celiac Disease Partly Explain the Variation?
    Am J Gastroenterol. 2015;110:1370-1.
    PubMed     Text format    


    August 2015
  90. PEYRIN-BIROULET L, Sandborn W, Sands BE, Reinisch W, et al
    Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
    Am J Gastroenterol. 2015 Aug 25. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  91. DAI C, Jiang M, Sun MJ
    The Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS.
    Am J Gastroenterol. 2015;110:1242-3.
    PubMed     Text format    


  92. MENEES S, Powell C, Chey WD
    Response to Dai et al.
    Am J Gastroenterol. 2015;110:1243-4.
    PubMed     Text format    


  93. BOSCHETTI G, Drai J, Flourie B, Nancey S, et al
    Response to Dai et al.
    Am J Gastroenterol. 2015;110:1242.
    PubMed     Text format    


  94. DAI C, Jiang M, Sun MJ
    Levels of fecal calprotectin and the severity of postoperative patients with Crohn's disease.
    Am J Gastroenterol. 2015;110:1241-2.
    PubMed     Text format    


    July 2015
  95. KOPYLOV U, Yablecovitch D, Lahat A, Neuman S, et al
    Detection of Small Bowel Mucosal Healing and Deep Remission in Patients With Known Small Bowel Crohn's Disease Using Biomarkers, Capsule Endoscopy, and Imaging.
    Am J Gastroenterol. 2015 Jul 28. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  96. FRELING E, Baumann C, Cuny JF, Bigard MA, et al
    Cumulative Incidence of, Risk Factors for, and Outcome of Dermatological Complications of Anti-TNF Therapy in Inflammatory Bowel Disease: A 14-Year Experience.
    Am J Gastroenterol. 2015 Jul 21. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  97. HIGGINS PD
    Miles to Go on the SCENIC Route: Should Chromoendoscopy Become the Standard of Care in IBD Surveillance?
    Am J Gastroenterol. 2015;110:1035-7.
    PubMed     Text format     Abstract available


  98. SONNENBERG A, Genta RM
    Low Prevalence of Colon Polyps in Chronic Inflammatory Conditions of the Colon.
    Am J Gastroenterol. 2015;110:1056-61.
    PubMed     Text format     Abstract available


    June 2015
  99. TARGOWNIK LE, Sexton KA, Bernstein MT, Beatie B, et al
    The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2015 Jun 16. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  100. CHRISTENSEN KR, Steenholdt C, Buhl SS, Ainsworth MA, et al
    Systematic Information to Health-Care Professionals about Vaccination Guidelines Improves Adherence in Patients With Inflammatory Bowel Disease in Anti-TNFalpha Therapy.
    Am J Gastroenterol. 2015 Jun 2. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  101. VAN ASSCHE G, Manguso F, Zibellini M, Nuno JL, et al
    Corrigendum: Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study.
    Am J Gastroenterol. 2015;110:943.
    PubMed     Text format    


  102. SCHOEPFER A, Reinisch W
    Editorial: Serial Fecal Calprotectin and Lactoferrin Measurements for Early Diagnosis of Pouchitis After Proctocolectomy for Ulcerative Colitis: Is Pouchoscopy No Longer Needed?
    Am J Gastroenterol. 2015;110:888-90.
    PubMed     Text format     Abstract available


  103. MAGRO F, Rodrigues-Pinto E, Coelho R, Andrade P, et al
    Response to Irwin et al.
    Am J Gastroenterol. 2015;110:933-5.
    PubMed     Text format    


  104. IRWIN J, Radford-Smith G
    Response to Magro et al.
    Am J Gastroenterol. 2015;110:931-2.
    PubMed     Text format    


  105. BOSCHETTI G, Laidet M, Moussata D, Stefanescu C, et al
    Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease.
    Am J Gastroenterol. 2015;110:865-72.
    PubMed     Text format     Abstract available


    May 2015
  106. KOLHO KL, Korpela K, Jaakkola T, Pichai MV, et al
    Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.
    Am J Gastroenterol. 2015 May 19. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  107. MOSLI MH, Zou G, Garg SK, Feagan SG, et al
    C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2015 May 12. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  108. PAUL S, Dronne W, Roblin X
    Kinetics of Antibodies Against Adalimumab Are Not Associated With Poor Outcomes in IBD.
    Am J Gastroenterol. 2015;110:777-8.
    PubMed     Text format    


    April 2015
  109. LINDOR KD, Kowdley KV, Harrison ME
    ACG Clinical Guideline: Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2015 Apr 14. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  110. PAREKH PJ, Oldfield Iv EC, Challapallisri V, Ware JC, et al
    Sleep disorders and inflammatory disease activity: chicken or the egg?
    Am J Gastroenterol. 2015;110:484-8.
    PubMed     Text format     Abstract available


    March 2015
  111. PAUL S, Roblin X
    Response to Bodini et al.
    Am J Gastroenterol. 2015;110:473.
    PubMed     Text format    


  112. HIGGINS PD, Fletcher JG
    Editorial: characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.
    Am J Gastroenterol. 2015;110:441-3.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: